Open: 80.33 Close: 80.65 Change: 0.32

Today's Summary

Analyst Expectations For Ionis Pharmaceuticals Future are based on recent analyst actions. Analyst ratings convey expectations for the relative performance of Ionis. Analysts explore the dynamics of price targets, providing estimates for the future value. Regeneron Pharmaceuticals is expanding its investment in gene editing through a $150 million partnership with Tessera Therapeutics. Ionis Pharmaceuticals received a Breakthrough Therapy designation for olezarsen for severe hypertriglyceridemia.